Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
A new resource for survivors helps guide life after cancer diagnosis and treatment.
People living with cancer are at higher risk for severe illness and death due to COVID-19.
The coronavirus vaccines are safe and should be effective even for people with advanced cancer.
The National Comprehensive Cancer Network and the American Cancer Society are leading efforts to resume cancer screenings and treatment.
New study reveals that more work is needed to enhance adherence to recommended cancer screening in Canada.
Ethan Zohn, who had Hodgkin lymphoma in 2009 and 2011, supports cancer survivor wellness with the National Comprehensive Cancer Network.
The National Comprehensive Cancer Network announces new free cancer survivorship resources.
Study finds bone health testing for patients with prostate cancer undergoing ADT therapy are not meeting guideline recommendations.
The NCCN publishes free treatment recommendations for pediatric Hodgkin lymphoma, adding to growing library of pediatric cancer guidelines.
New NCCN Guidelines for Patients: Pediatric Acute Lymphoblastic Leukemia offers a comprehensive look at the latest expert recommendations.
New research discusses how immunotherapy-related adverse events (irAEs) can impact more than one organ in a single patient.
The NCCN Distress Thermometer enables discussion and treatment of distress as part of routine care for people with cancer.
New research from UCSF and City of Hope examines limitations in coverage for liquid biopsy genomic testing in cancer care.
Information for patients and caregivers on how to manage adverse events from immune checkpoint inhibitors
New NCCN guidelines explain how to recognize and manage immunotherapy-related toxicities.
Researchers discover 40.2% of advanced cancer patients with unplanned hospitalizations experienced functional impairment.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.